0001053691-17-000001.txt : 20170316
0001053691-17-000001.hdr.sgml : 20170316
20170316162810
ACCESSION NUMBER: 0001053691-17-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20170316
DATE AS OF CHANGE: 20170316
EFFECTIVENESS DATE: 20170316
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Diffusion Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001053691
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 300645032
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-282760
FILM NUMBER: 17694915
BUSINESS ADDRESS:
STREET 1: 2020 AVON COURT
STREET 2: SUITE 4
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
BUSINESS PHONE: (434) 220-0718
MAIL ADDRESS:
STREET 1: 2020 AVON COURT
STREET 2: SUITE 4
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
FORMER COMPANY:
FORMER CONFORMED NAME: RestorGenex Corp
DATE OF NAME CHANGE: 20140307
FORMER COMPANY:
FORMER CONFORMED NAME: Stratus Media Group, Inc
DATE OF NAME CHANGE: 20080722
FORMER COMPANY:
FORMER CONFORMED NAME: FERIS INTERNATIONAL, INC.
DATE OF NAME CHANGE: 20080228
D
1
primary_doc.xml
X0707
D
LIVE
0001053691
Diffusion Pharmaceuticals Inc.
2020 AVON COURT
SUITE 4
CHARLOTTESVILLE
VA
VIRGINIA
22902
(434) 220-0718
DELAWARE
RestorGenex Corp
Stratus Media Group, Inc
FERIS INTERNATIONAL, INC.
Corporation
true
David
G.
Kalergis
2020 Avon Court
Suite 4
Charlottesville
VA
VIRGINIA
22902
Executive Officer
Director
Mark
T.
Giles
2020 Avon Court
Suite 4
Charlottesville
VA
VIRGINIA
22902
Director
John
L.
Gainer
2020 Avon Court
Suite 4
Charlottesville
VA
VIRGINIA
22902
Executive Officer
Director
Isaac
Blech
2020 Avon Court
Suite 4
Charlottesville
VA
VIRGINIA
22902
Director
Robert
W.
Adams
2020 Avon Court
Suite 4
Charlottesville
VA
VIRGINIA
22902
Director
Alan
G.
Levin
2020 Avon Court
Suite 4
Charlottesville
VA
VIRGINIA
22902
Director
Ben
L.
Shealy
2020 Avon Court
Suite 4
Charlottesville
VA
VIRGINIA
22902
Executive Officer
Thomas
S.
Byrne
2020 Avon Court
Suite 4
Charlottesville
VA
VIRGINIA
22902
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06b
false
2017-03-14
false
true
true
true
false
0
Maxim Group LLC
120708
None
None
405 Lexington Avenue
New York
NY
NEW YORK
10174
All States
true
25000000
15830661
9169339
false
145
1498066
true
0
Maxim Group LLC will also receive a 5-year warrant to purchase shares of common stock equal to no more than 10% of the aggregate number of shares of preferred stock sold. Maxim will receive additional commissions on any additional sales in the offering.
0
A portion of the proceeds may be used for general corporate purposes, including to pay salaries of some related persons listed in Item 3.
false
Diffusion Pharmaceuticals Inc.
/s/ David G. Kalergis
David G. Kalergis
Chairman & CEO
2017-03-16